South Africa has placed the Oxford-AstraZeneca vaccine on hold after a study showed “disappointing” results against its new Covid-19 variant.
Africa’s hardest-hit nation (South Africa) was due to start its campaign in the coming days with a million doses of the vaccine developed by AstraZeneca and Oxford.
The suspension marks an important setback for the country, but officials said vaccine deliveries from other producers would soon be available and allow the campaign to move forward.
The study, involving around 2,000 people, found the vaccine offered “minimal protection” against mild and moderate cases of Covid-19.
Speaking on an online news conference this sunday, 7th February, 2021, South Africa Health Minister Zweli Mkhize said, the government would wait for further advice on how to proceed with the Oxford-AstraZeneca vaccine in light of the findings.